Clinical Trials
3 trialsNCT05488314 2026-06-05
METalmark
Janssen Research & Development, LLC
Phase 1/2 Active not recruiting
NCT05642572 2026-06-03
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
SWOG Cancer Research Network
Phase 2 Recruiting
NCT05703516 2026-06-01
A Post Approval Commitment Study on Tabrecta® (Capmatinib) in South Korea
Novartis
Recruiting